Cited by 139Adrenal Hormones and DisordersPituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing’s syndrome: a systematic review of the literature

Di Dalmazi, Guido, Berr, Christina M., Fassnacht, Martin, Beuschlein, Felix, Reincke, Martin·2014·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: The postoperative course of patients with subclinical hypercortisolism (SH) is yet to be clarified. The aims are to review the prevalence and predictive factors of postoperative adrenal insufficiency and the time to recover a normal adrenocortical function in patients with SH and Cushing's syndrome (CS). EVIDENCE ACQUISITION: Using the PubMed database, we conducted a systematic review of the literature, selecting studies published from 1980 to 2013. EVIDENCE SYNTHESIS: Of the 1522 papers screened, 28 were selected (13 retrospective, 14 prospective, and one randomized controlled trial). The prevalence of postoperative adrenal insufficiency was 65.3% in 248 SH subjects and 99.7% in 377 CS patients. Patients with SH were reclassified according to the following diagnostic criteria: subjects defined by pathological dexamethasone test only (DEX), and those defined by the dexamethasone test with one (DEX+1) or two additional criteria (DEX+2); and they were compared with CS patients. The prevalence of adrenal insufficiency was 51.4, 60.6, 91.3, and 99.7%, respectively, with no significant difference between the two latter groups. The test with the best compromise between sensitivity (64%) and specificity (81%) in predicting adrenal insufficiency was the midnight serum cortisol. The time to achieve eucortisolism was lower in SH patients than in CS patients (6.5 vs 11.2 mo; P < .001). CONCLUSIONS: Adrenal insufficiency occurs in about half of the patients with SH if defined only by the pathological dexamethasone test. However, prevalence of adrenal insufficiency and time to recovery are tightly related to the degree of hypercortisolism and diagnostic criteria to define SH, which might help to better define SH for future studies.

Integrity signals

Registry

Crossref · 10.1210/jc.2014-1401

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Even though treatment regimens, route of administration, potency, dose, duration of glucocorticoid treatment, as well as individual glucocorticoid sensitivity, have been postulated as potential risk factors for glucocorticoid-induced AI, no clear-cut predictive factors of risk of onset and duration of AI before HPA axis recovery have been identified so far.

    “Even though treatment regimens, route of administration, potency, dose, duration of glucocorticoid treatment, as well as individual glucocorticoid sensitivity, have been postulated as potential risk factors for glucocorticoid-induced AI, no clear-cut predictive factors of risk of onset and duration of AI before HPA axis recovery have been identified so far (15, 16, 20, 21).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Di Dalmazi, G., Berr, C. M., Fassnacht, M., Beuschlein, F., & Reincke, M.
Affiliations
  • Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, D-80336 München, Germany
  • LMU Klinikum (DE)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2014-08-01
Volume
99
Issue
8
Pages
2637-2645
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2048388708
Cited by
139
References
13
Citations by year
2026: 6 · 2025: 16 · 2024: 15 · 2023: 11 · 2022: 13 · 2021: 18 · 2020: 15 · 2019: 7 · 2018: 13 · 2017: 8 · 2016: 11 · 2015: 6
FWCI
1.33
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Funders
Department of Science and Technology, Ministry of Science and Technology, India
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Keywords
subclinical hypercortisolism, Cushing's syndrome, adrenalectomy, postoperative adrenal insufficiency, dexamethasone suppression test
MeSH terms
Adrenal Insufficiency, Adrenal Glands, Adrenalectomy, Cushing Syndrome, Humans, Postoperative Complications, Prevalence, Asymptomatic Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review